Pricing

Abcuro

1 follower

‌

Abcuro is a clinical stage biotechnology company developing treatments for autoimmune and cancer indications modulated by cytotoxic T and NK cells that express the inhibitory immune checkpoint receptor KLRG1 (killer cell lectin-like receptor G1). The company is advancing ABC008, a first-in-class ant... Read more

Industries

Headquarters

Newton, United States

Employees

Links

Org chart

Chief Executive Officer

Alex Martin

Collapse

COO

H. Jeffrey Wilkins, MD

Chief Medical Officer

Ricky Motschwiller

Vice President Finance

Research VP, Head of Data Management

VP, Clinical Development & Head, Clinical Trial Management

Head, Corporate Development

Senior Director, Program Management

Hugo Lemessurier

Director

Director, Clinical Operations

VP, Information Technology

Director, Human Resources

Teams

Management and Directors

11 members

Leadership Team

5 members

Quality and Regulatory Team

7 members

Supply Chain and Manufacturing

7 members

Clinical Operations Team

5 members

Finance and Accounting Team

5 members

Offices

Similar companies

Calico

6 followers

Qualigen Therapeutics

3 followers

Vera Therapeutics

2 followers

Cargo

1 follower

Capricor Therapeutics

1 follower

Edgewise Therapeutics

1 follower

Cartesian Therapeutics

1 follower

ADARx Pharmaceuticals

3 followers

Thermo Fisher Scientific

180 followers

Gilead Sciences

136 followers

Biogen

123 followers

Explore companies